A randomized crossover trial assessing patient preference for two different types of portable infusion-pump devices

Annals of Oncology

Volumn 10, Issue 6, 1999, Pages 727-729

  Zahnd, D ^a   Aebi, S ^a   Rusterholz, S ^a   Fey, M F ^a   Borner, M M ^a  

^a UNIVERSITY OF BERN   (Switzerland)

Author keywords

Continuous infusion; Elastomeric; Fluorouracil; Mechanical; Patient preference; Portable pump

Indexed keywords

FLUOROURACIL;

ARTICLE; BREAST CANCER; CLINICAL ARTICLE; CLINICAL TRIAL; CONTINUOUS INFUSION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DEVICE; DIGESTIVE SYSTEM CANCER; DRUG DELIVERY SYSTEM; EVALUATION; FEMALE; HUMAN; INFUSION PUMP; MALE; PATIENT SATISFACTION; PRIORITY JOURNAL; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; STATISTICAL ANALYSIS;

AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS; CROSS-OVER STUDIES; FEMALE; HUMANS; INFUSION PUMPS; MALE; MIDDLE AGED; PATIENT SATISFACTION; QUALITY OF LIFE;

EID: 0032782821     PISSN: 09237534     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1008334313918     Document Type: Article

References (9)

1. Vogelzang NJ. Continuous infusion chemotherapy: A critical review. J Clin Oncol 1984; 2: 1289 304.
2. Lokich J, Anderson N. Dose intensity for bolus versus infusion chemotherapy administration: Review of the literature for 27 anti-neoplastic agents. Ann Oncol 1997; 8: 15-25.
3. Armitage P, Berry G. Statistical Methods in Medical Research. Oxford: Blackwell Scientific Publications 1987.
4. Miettinen OS. Estimation of relative risk from individually matched series. Biometrics 1970; 26: 75-86.
5. Valente M, Aldrete JA. Comparison of accuracy and cost of disposable, nonmechanical pumps used for epidural infusions. Reg Anesth 1997; 22: 260-6.
6. Yokes EE, Schilsky RL, Choi KE. A randomized study of inpatient Yersus outpatient continuous infusion chemotherapy for patients with locally advanced head and neck cancer. Cancer 1989; 63: 30-6.
7. Hoff P, Pazdur R, Benner S, Canetta R. UFT and leucovorin: A review of its clinical development and therapeutic potential in the oral treatment of cancer. Anti-Cancer Drugs 1998; 9: 479 90.
8. Mackean M, Planting A, Twelves C et al. Phase I and pharmacologic study of intermittent twice-daily oral therapy with capecitabine in patients with advanced and/or metastatic cancer. J Clin Oncol 1998; 16: 2977-85.
9. Sobrero A, Aschele C, Bertino J. Fluorouracil in colorectal cancer - a tale of two drugs: Implications for biochemical modulation. J Clin Oncol 1997; 15: 368-81.